Profile
Paul W.
Hawran is the founder of Biora Therapeutics, Inc. (2010), Neurocrine Biosciences, Inc. (1993), and Ascendant MDx, Inc. (2010).
He held the title of Chief Financial Officer & Senior Vice President at Neurocrine Biosciences, Inc. from 1993 to 2007.
Mr. Hawran currently holds membership positions at The American Institute of Certified Public Accountants, The Financial Executives Institute, Pennsylvania Institute of Certified Public Accountants, and California Society of Certified Public Accountants.
He previously held the position of Independent Director at Plus Therapeutics, Inc. from 2011 to 2017.
He was also the Chief Financial Officer at Sequenom, Inc. from 2006 to 2009 and Treasurer & Vice President at GSK Plc from 1984 to 1993.
Mr. Hawran's education includes an undergraduate degree from St. John's University and a graduate degree from Seton Hall University.
Paul Hawran active positions
| Companies | Position | Start |
|---|---|---|
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Corporate Officer/Principal | - |
California Society of Certified Public Accountants | Corporate Officer/Principal | - |
The Financial Executives Institute | Corporate Officer/Principal | - |
Former positions of Paul Hawran
| Companies | Position | End |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Director/Board Member | 2017-04-30 |
Ascendant MDx, Inc. | Chief Executive Officer | - |
| SEQUENOM, INC. | Director of Finance/CFO | 2009-09-27 |
| NEUROCRINE BIOSCIENCES, INC. | Founder | 2007-03-31 |
| GSK PLC | Treasurer | 1993-04-30 |
Training of Paul Hawran
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Warner Communications, Inc.
Warner Communications, Inc. Cable/Satellite TVConsumer Services Engages in entertainment communications services | Consumer Services |
Sequenom, Inc.
Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The Financial Executives Institute | |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Commercial Services |
California Society of Certified Public Accountants | Commercial Services |
Ascendant MDx, Inc. | |
Biora Therapeutics, Inc.
Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Paul Hawran
















